Author： Jabbour Elias Kantarjian Hagop M Garcia-Manero Guillermo Issa Jean-Pierre J
Publisher： Future Medicine
ISSN： 1475-0708
Source： Therapy, Vol.2, Iss.6, 2005-11, pp. : 835-842
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Myelodysplastic Syndromes in the Elderly
JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 40, Iss. 4, 1992-04 ,pp. :
Access to resources
Recommend
The myelodysplastic syndromes: the era of understanding
EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 5, 2015-05 ,pp. :
Anticardiolipin Antibodies in Myelodysplastic Syndromes
Acta Haematologica, Vol. 101, Iss. 3, 1999-05 ,pp. :
Autoimmunity and Inflammation in Myelodysplastic Syndromes
Acta Haematologica, Vol. 136, Iss. 2, 2016-06 ,pp. :
Thrombopoiesis‐stimulating agents and myelodysplastic syndromes
BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. :